Disclaimer: This petition was created and is led by me, Amanda Bonello, in my personal capacity as an individual advocate
Regulatory agencies including the FDA and UK MHRA have issued warnings about unlicensed MTII products marketed for tanning
Before your first visit Blood work required: Routine blood work within the last 12 months is required before your first appointment to obtain a baseline status and assess safety, effectiveness, and overall management
Recent evidence supports the safe combined use of SGLT-2 inhibitors and GLP-1 RAs 82 and that the benefits of finerenone are independent of GLP-1 RA treatment in people with DKD
It blocks clotting factor Xa, slowing clot formation and lowering the chance of stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and clot recurrence after hip or knee replacement
Subscribe to our YouTube channel here